John Goldman
speaker
924 appearances
1 recordings
1 series
first heard Jun 2026
last heard 10 Jun
John Goldman’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jun 2026 with 1.
Appearances
I mean, when used as prescribed, generally speaking, what we have seen is that it's extremely effective inducing weight loss and therefore benefiting your metabolic health and your insulin resistance and turning you into an insulin sensitive person, which is what you want.
Most all of us unhealthy folks are insulin resistant.
It means your insulin is on overdrive.
You've got high levels of insulin.
You're not shuttling nutrients around where they need to go.
You live in a constant state of inflammation and you're building up plaque in your arteries and you could lead to diabetes and arteriosclerosis and cardiovascular disease and all these terrible things.
So semaglutide, and then its predecessor or predecessor?
Yeah, the one that comes after.
Successor, I guess.
Its successor, terzepatide, and then redditrutide is the latest one that's about ready to get FDA approval here in the States.
These act on different areas of your body besides ozempic.
It's like ozempic plus one and then ozempic plus two for redditrutide.
And we've seen Terzapatide.
I think the brand name is Munjaro for that.
Yeah, Munjaro.
Yeah, Munjaro.
We've seen just amazing results.
You take it as prescribed.
You do the stepped up scaling.
Side effects are minimal.
Showing 441–460 of 924 · page 23 of 47
← Previous
Next →